Cargando…

Routine vaccination against MenB: Considerations for implementation

Effective polysaccharide(conjugate) vaccines against Neisseria meningitidis serogroups A, C, W, and Y have been widely used, but serogroup B meningococci remain a major cause of severe invasive meningococcal disease (IMD) worldwide, especially in infants. Recently, a vaccine, 4CMenB (Bexsero(®)), co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaaijk, Patricia, van der Ende, Arie, Luytjes, Willem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185901/ https://www.ncbi.nlm.nih.gov/pubmed/24141209 http://dx.doi.org/10.4161/hv.26816

Ejemplares similares

Vaccination against Lyme disease: Are we ready for it?
por: Kaaijk, Patricia, et al.
Publicado: (2015)

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?
por: Kaaijk, Patricia, et al.
Publicado: (2013)

Are we prepared for emerging flaviviruses in Europe? Challenges for vaccination
por: Kaaijk, Patricia, et al.
Publicado: (2017)

The Long Road to an Effective Vaccine for Meningococcus Group B (MenB)
por: Shea, Michael W.
Publicado: (2013)

Phase Variation of NadA in Invasive Neisseria meningitidis Isolates Impacts on Coverage Estimates for 4C-MenB, a MenB Vaccine
por: Green, Luke R., et al.
Publicado: (2018)

Health and Economic Outcomes of Introducing the New MenB Vaccine (Bexsero) into the Italian Routine Infant Immunisation Programme
por: Tirani, Marcello, et al.
Publicado: (2015)

Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England
por: Christensen, Hannah, et al.
Publicado: (2017)

A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
por: McDaniel, Angee, et al.
Publicado: (2019)

Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
por: Breton, Marie-Claude, et al.
Publicado: (2020)

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement
por: Hogea, Cosmina, et al.
Publicado: (2015)

Perceptions and Knowledge About the MenB Vaccine Among Parents of High School Students
por: Richardson, Eric, et al.
Publicado: (2021)

UK parents’ attitudes towards meningococcal group B (MenB) vaccination: a qualitative analysis
por: Jackson, Cath, et al.
Publicado: (2017)

Multi‐component meningococcal serogroup B (MenB)‐4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency
por: van den Broek, B., et al.
Publicado: (2019)

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015)
por: Tryfinopoulou, Kyriaki, et al.
Publicado: (2016)

MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2020)

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States
por: Rajam, Gowrisankar, et al.
Publicado: (2017)

01. Serum Bactericidal Activity Against Circulating and Reference Strains of Meningococcal Serogroup B in the United States: A Review of Meningococcal Serogroup B (MenB) Vaccines in Adolescents and Young Adults
por: Coyne-Beasley, Tamera, et al.
Publicado: (2021)

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
por: Kaaijk, Patricia, et al.
Publicado: (2012)

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2019)

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults
por: Presa, Jessica, et al.
Publicado: (2023)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018–2020
por: Stefanizzi, Pasquale, et al.
Publicado: (2022)

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage
por: Sereikaitė, Emilija, et al.
Publicado: (2023)

6. Pentavalent Meningococcal (MenABCWY) Vaccine is Safe and Well Tolerated With Immunogenicity Noninferior to Coadministered MenB-FHbp and MenACWY-CRM in a Phase 2 Study of Healthy Adolescents and Young Adults
por: Peterson, James, et al.
Publicado: (2020)

Genomic sequencing in oncology: Considerations for integration in routine cancer care
por: Rahman, Belinda, et al.
Publicado: (2022)

Erratum for Rajam et al., “Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States”
por: Rajam, Gowrisankar, et al.
Publicado: (2019)

Considerations for routinely testing for high lipoprotein(a)
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Four New Vaccines for Routine Immunization in India: What About Hemophilus Influenza B and Pneumococcal Vaccine?
por: Paul, Sourabh, et al.
Publicado: (2015)

Pharmacoepidemiological considerations in observed‐to‐expected analyses for vaccines
por: Mahaux, Olivia, et al.
Publicado: (2015)

Considerations in Understanding Vaccine Effectiveness
por: Lau, Chin Shern, et al.
Publicado: (2022)

Considerations for the development and implementation of electronic immunization registries in Africa
por: Namageyo-Funa, Apophia, et al.
Publicado: (2018)

Routine Antigen Testing Is Not a Substitute for Health Care Worker Vaccination against SARS-CoV-2
por: Sexton, Mary Elizabeth, et al.
Publicado: (2021)

The case for ring vaccinations with special consideration of oral cholera vaccines
por: Deen, Jacqueline, et al.
Publicado: (2018)

Considerations for the rational design of a Chlamydia vaccine
por: Liang, Steven, et al.
Publicado: (2016)

Inoculating against COVID-19 vaccine misinformation
por: van der Linden, Sander, et al.
Publicado: (2021)

Decreasing routine vaccination rates in children in the COVID-19 era
por: Maltezou, Helena C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fa1bsve8g38fvh08epcdc0kaq